Tracking of second primary melanomas in vemurafenib-treated patients

JAMA Dermatol. 2013 Apr;149(4):488-90. doi: 10.1001/jamadermatol.2013.21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Dermoscopy / methods
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Melanoma / diagnosis
  • Melanoma / drug therapy
  • Melanoma / secondary*
  • Microscopy, Confocal
  • Middle Aged
  • Neoplasms, Second Primary*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / secondary*
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Indoles
  • Sulfonamides
  • Vemurafenib